Mutational Analysis of<i>Smad3</i>, a Candidate Tumor Suppressor Implicated in TGF-β and Menin Pathways, in Parathyroid Adenomas and Enteropancreatic Endocrine Tumors
Trisha M. Shattuck(University of Connecticut), Andrew Arnold(University of Connecticut), Daniel C. Chung(Massachusetts General Hospital), Jessica L. Costa(University of Connecticut), Robert T. Jensen(National Institutes of Health), Megan Bernstein(University of Connecticut)
Cited by 39
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k
The Chromosomal Instability Pathway in Colon Cancer
|Gastroenterology|2010|932